启明医疗(02500.HK) 公布,于昨日(10日)交易时段后,与认购人杭州盈智勤(参)号股权投资合伙企业订立协议,将配发1.85亿股待认购股份及本金额不超过3.797亿港元的可转换债券。待认购股份倘若为H股,代价为近1.99亿港元;倘若为内资股,代价为约1.72亿元人民币。每股待认购股份认购价为1.078港元,较前交易日(9日)收市价折让10.9%。待认购股份将占公司经扩大已发行股本约29.5%...
Source Link启明医疗(02500.HK) 公布,于昨日(10日)交易时段后,与认购人杭州盈智勤(参)号股权投资合伙企业订立协议,将配发1.85亿股待认购股份及本金额不超过3.797亿港元的可转换债券。待认购股份倘若为H股,代价为近1.99亿港元;倘若为内资股,代价为约1.72亿元人民币。每股待认购股份认购价为1.078港元,较前交易日(9日)收市价折让10.9%。待认购股份将占公司经扩大已发行股本约29.5%...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.